Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alzheimer's Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alzheimer's Drugsmarket, defines the market attractiveness level of Alzheimer's Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alzheimer's Drugs industry, describes the types of Alzheimer's Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alzheimer's Drugs market and the development prospects and opportunities of Alzheimer's Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alzheimer's Drugs market in Chapter 13.
By Player:
Biogen
Johnson & Johnson
Allergan
Eisai Pharmaceuticals
Novartis
Pfizer
Amgen
By Type:
Acetylcholinesterase (AChE) Inhibitors
Glutamate Inhibitors
Other
By End-User:
Under 65 Years Old
65 and Above 65 Years Old
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alzheimer's Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alzheimer's Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alzheimer's Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alzheimer's Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alzheimer's Drugs Market Analysis and Outlook to 2022
-
7.1 Global Alzheimer's Drugs Consumption (2017-2022)
-
7.2 United States Alzheimer's Drugs Consumption (2017-2022)
-
7.3 Europe Alzheimer's Drugs Consumption (2017-2022)
-
7.4 China Alzheimer's Drugs Consumption (2017-2022)
-
7.5 Japan Alzheimer's Drugs Consumption (2017-2022)
-
7.6 India Alzheimer's Drugs Consumption (2017-2022)
-
7.7 South Korea Alzheimer's Drugs Consumption (2017-2022)
8 Region and Country-wise Alzheimer's Drugs Market Analysis and Outlook to 2028
-
8.1 Global Alzheimer's Drugs Consumption Forecast (2022-2028)
-
8.2 United States Alzheimer's Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Alzheimer's Drugs Consumption Forecast (2022-2028)
-
8.4 China Alzheimer's Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Alzheimer's Drugs Consumption Forecast (2022-2028)
-
8.6 India Alzheimer's Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Alzheimer's Drugs Consumption Forecast (2022-2028)
9 Global Alzheimer's Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Alzheimer's Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Acetylcholinesterase (AChE) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Glutamate Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Alzheimer's Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Under 65 Years Old Consumption and Growth Rate (2017-2022)
-
9.2.2 Global 65 and Above 65 Years Old Consumption and Growth Rate (2017-2022)
10 Global Alzheimer's Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Alzheimer's Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Acetylcholinesterase (AChE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Glutamate Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alzheimer's Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Under 65 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global 65 and Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)
11 Global Alzheimer's Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alzheimer's Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alzheimer's Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alzheimer's Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alzheimer's Drugs Market Competitive Analysis
-
14.1 Biogen
-
14.1.1 Biogen Company Details
-
14.1.2 Biogen Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Alzheimer's Drugs Product and Service
-
14.2 Johnson & Johnson
-
14.2.1 Johnson & Johnson Company Details
-
14.2.2 Johnson & Johnson Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Johnson & Johnson Alzheimer's Drugs Product and Service
-
14.3 Allergan
-
14.3.1 Allergan Company Details
-
14.3.2 Allergan Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allergan Alzheimer's Drugs Product and Service
-
14.4 Eisai Pharmaceuticals
-
14.4.1 Eisai Pharmaceuticals Company Details
-
14.4.2 Eisai Pharmaceuticals Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eisai Pharmaceuticals Alzheimer's Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Alzheimer's Drugs Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Alzheimer's Drugs Product and Service
-
14.7 Amgen
-
14.7.1 Amgen Company Details
-
14.7.2 Amgen Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amgen Alzheimer's Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alzheimer's Drugs
-
Figure Alzheimer's Drugs Picture
-
Table Global Alzheimer's Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer's Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alzheimer's Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alzheimer's Drugs Consumption by Country (2017-2022)
-
Figure United States Alzheimer's Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Alzheimer's Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Alzheimer's Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Alzheimer's Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Alzheimer's Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alzheimer's Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Alzheimer's Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alzheimer's Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alzheimer's Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alzheimer's Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alzheimer's Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alzheimer's Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acetylcholinesterase (AChE) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamate Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Under 65 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global 65 and Above 65 Years Old Consumption and Growth Rate (2017-2022)
-
Figure Global Acetylcholinesterase (AChE) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamate Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Under 65 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 65 and Above 65 Years Old Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alzheimer's Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alzheimer's Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Alzheimer's Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Alzheimer's Drugs Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Alzheimer's Drugs Product and Service
-
Table Eisai Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Eisai Pharmaceuticals Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Pharmaceuticals Alzheimer's Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Alzheimer's Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Alzheimer's Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Alzheimer's Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Alzheimer's Drugs Product and Service
-
